Abstract:Objective To study the immunosuppressive activity of MSC from controls or patients with AA in vitro. Methods Bone marrow samples were collected from patients with A A at diagnosis[n= 24, 12 from severe aplastic ane-mia(SAA) , 12 from chronic aplastic anemia(CAA)]and the patients whose findings of bone marrow aspiration were nor-mal as the controls (n= 11). MSCs from bone marrow samples were isolated, cultured and expanded. Morphology, pro-liferative activity and colony forming unit-fibroblast (CFU-F) were measured and analyzed. MSC were assayed for the activity of lymphocytes suppression by mixed lymphocyte reaction (MLR). The hepatocyte growth factor and transforming growth factor-β1 mRNA expression were detected by RT-PCR. HGF and TGF-β1 concentrations of MSC were tested by enzyme-linked immunosorbent assay (ELISA). Results (l) The culture cells from the patients with AA presented a typical fibroblast-like morphology. The number of CFU-F from the patients with AA (15.70±5.78) was fewer than that from the controls (22.33±5.33) , t = -2.74, P < 0.05. (2) The inhibition ratio of MSC from patients with AA[(49.78± 20.36)% ]was significantly lower than that from the controls[(76.42±8.80)% ], t=3.48, P < 0.01. (3) The level of TGF-βl mRNA expression in MSC from patients with AA was significantly lower than the controls, t = -3.34,P < 0.01, and the level of HGF mRNA expression in MSC from patients with AA was significantly lower than the controls, t = -2.54, P < 0.05. (4) The concentration of TGF-β1 in MSC supernatants from the patients with AA [(415.09±108.10) pg/ml] was significantly lower than the con-trols [(632.40±126.90) pg/ml], t =-2.48, P < 0.05; the concentration of HGF in MSC supernatants from the patients with AA [(340.72±40.44) pg/ml] was significantly lower than that from the controls [(521.56±36.72)pg/ml], t = -2.46, P < 0.05. All these differences were of statistical significance. Conclusion The suppressive effect of MSC from patients with AA in vitro is significant-ly decreased. Its mechanism may be related to the decreased proliferative capacity, TGF-β1, HGF mRNA expression level in MSC and TGF-β1, HGF release activity.

Alterations of mesenchymal stem cells on regulating Th17 and Treg differentiation in severe aplastic anemia

Reduced Regulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Activated T Lymphocytes and Th1/Th2 Cytokine Secretion in Children with Aplastic Anemia.

Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4(+) T cells in aplastic anemia.

Study on the Immunoregulation of Mesenchymal Stem Cells from Patients with Aplastic Anemia

Abnormal Immunomodulatory Ability on Memory T Cells in Humans with Severe Aplastic Anemia.

Exosomal sphingosine 1-phosphate secreted by mesenchymal stem cells regulated Treg/Th17 balance in aplastic anemia.

Differential Gene Expression Profile Associated with the Abnormality of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia.

T-cell suppression mediated by mesenchymal stem cells in patients with chronic aplastic anemia

Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia

Abnormal Quantity And Function Of Th17 Cells In Patients With Severe Aplastic Anemia Combined With Infection

Reduced Intensity Conditioning, Combined Transplantation of Haploidentical Hematopoietic Stem Cells and Mesenchymal Stem Cells in Patients with Severe Aplastic Anemia.

Single-cell Analysis Highlights a Population of Th17-polarized CD4+ Naïve T Cells Showing IL6/JAK3/STAT3 Activation in Pediatric Severe Aplastic Anemia

Hematopoiesis Support of Mesenchymal Stem Cells in Children with Aplastic Anemia

[Osteogenic and Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Aplastic Anemia].

Comparative Proteomic Analysis of CD34+ Cells in Bone Marrow Between Severe Aplastic Anemia and Normal Control

Effects of allogeneic bone marrow mesenchymal stem cells on T lymphocytes in patients with severe aplastic anemia

Abnormal Quantity and Function of Regulatory T Cells in Peripheral Blood of Patients with Severe Aplastic Anemia

Bone marrow CD8+ Trm cells induced by IL-15 and CD16+ monocytes contribute to HSPC destruction in human severe aplastic anemia

Impaired immunosuppressive role of myeloid-derived suppressor cells in acquired aplastic anemia

Treatment of Severe Aplastic Anemia with Transplantation of Combined Haploidentical Hematopoietic Stem Cells and Mesenchymal Stem Cells: A Case Report

A Cohort Study of Immune and Hematopoietic Functionality Changes in Severe Aplastic Anemia Patients Treated with Immunosuppressive Therapy.